Navigation Links
Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato(R) Loxapine) in North America
Date:2/10/2010

age with a stainless steel substrate, onto which a thin film of drug is coated.  When the patient draws a single normal breath through the Staccato device, the substrate surface instantly heats to create an aerosol of optimally-sized, excipient-free particles of drug that are drawn into the patient's lungs. The entire Staccato system actuation and drug delivery occur in less than one second.

The Staccato system is unique among inhalers because it uses no excipients, requires no special breathing maneuvers and there are no controls to deal with.   The system produces a consistently high emitted dose, regardless of the patient's breathing pattern, and doses are pre-set.  About the size of a small cell phone, the unit fits easily in a pocket or purse.

Alexza has screened more than 400 drug compounds and more than 200 drug compounds exhibit initial vaporization feasibility with the Staccato system.  Since the filing of its first IND in 2004, Alexza has dosed more than 2,600 patients and subjects with its Staccato technology, in 22 different clinical trials under six different INDs for Staccato-based product candidates.

Conference Call Information

Alexza will host a conference call Wednesday morning, February 10, 2010, at 8:30 a.m. Eastern Time.  A replay of the call will be available for two weeks following the event.  The conference call and replay are open to all interested parties.  

To access the conference call via the Internet, go to www.alexza.com, under the "Investor Relations" link.  Please join the call at least 15 minutes prior to the star
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Alexza to Announce 2009 Second Quarter Financial Results and Update Its Clinical Pipeline Status on Wednesday, August 5, 2009
2. A Random Act of Kindness Changes a Familys Life Forever as Alexzander Prados Wish to Walk is Granted at Abilities Expo
3. Alexza Announces Agreement to Acquire Symphony Allegro, Including All Rights to AZ-004, AZ-104 and AZ-002
4. Alexzas Corporate Presentation to be Webcast at the Piper Jaffray Fourth Annual Europe Conference
5. Alexzas Corporate Presentation to be Webcast at the Eighth Annual JMP Securities Research Conference
6. Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status
7. Alexzas Corporate Presentation to be Webcast at the Cowen & Company 29th Annual Health Care Conference
8. Alexza to Announce 2008 Financial Results and Update Its Clinical Pipeline on Tuesday, March 10, 2009
9. Alexza Pharmaceuticals Promotes Peter D. Noymer, PhD to Vice President, Product R&D
10. Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts
11. Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... September 03, 2015 , ... B. E. Smith, the only ... lead a national chief executive officer recruitment for Melissa Memorial Hospital ... industry, B. E. Smith has recently placed more than 1,000 healthcare executives into ...
(Date:9/3/2015)... ... ... Global Vision , the world leader in the development of innovative ... inspection solutions, ScanProof and ArtProof at Packaging Innovations 2015. , Join ... , Be the first to get a sneak peek of Intelligent Proofreading. Global Vision’s ...
(Date:9/3/2015)... ... September 03, 2015 , ... DiabetesSisters ... pleased to announce the additional of Carol Wysham, MD, to their esteemed Board ... Diana Karczmarczyk, Donna Rice, David Warren, Matt Stella, Tricia Cedotal, Andrea Thomas, Wanda ...
(Date:9/3/2015)... ... ... ProScrub is a set of automated tools that allow Final Cut Pro ... without the use of keyframes. Utilize ProScrub's powerful sliders to determine the number ... to energetic video productions. ProScrub is a Final Cut Pro X ...
(Date:9/3/2015)... ... 03, 2015 , ... AvePoint, the established leader in enabling enterprise ... 4 – AvePoint’s solution for facilitating two-way collaboration and external sharing without ever ... This is the fifth consecutive year an AvePoint product has made the list. ...
Breaking Medicine News(10 mins):Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 3Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3Health News:Carol H. Wysham, MD, Joins DiabetesSisters Board of Directors 2Health News:FCPX Effects Developer Releases ProScrub for Final Cut Pro X 2Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 2Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 3Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 4
... the disheartening reasons behind her recent weight loss. ... emaciated in all her recent public appearances, admitted that she ... revealed that her worrying weight loss is a result of ... lean and this year I lost my mom and I've ...
... Moylan of St.Lucie County was driven to a West ... for urgent treatment of a splitting headache. ... behind his right ear. And his wife April Moylan ... wife offered conflicting explanations throughout the day, the latter ...
... of the first studies of social sources of alcohol ... were willing to purchase alcohol for underage youth .Many ... Most of them obtain alcohol from social sources of ... opposed to commercial sources. , ,Many types ...
... to worry about the doctor's needle, for a new study ... just as well as injections. ,The first of ... showed that kids children given oral treatment recovered as quickly, ... were able to go home sooner than those given intravenous ...
... of CD38 gene prevented mice on high-fat diets from gaining weight. ... researchers led by Eduardo Chini at Mayo Clinic. ,As ... one with the gene CD38 and the other without. Each group ... fat. In a second test, each group was fed a standard ...
... Tuesday with the death of a ninth child who contracted ... centre said. ,The death came as a ... officials accused in the case for negligence, corruption and fraud. ... in prison. ,The accused have all denied the ...
Cached Medicine News:Health News:Headache Complaint Leads to Removal of Bullet 2Health News:Underage Youth Get Alcohol from Social Sources 2Health News:Underage Youth Get Alcohol from Social Sources 3Health News:Oral Treatment as Effective as Injections in Treating Kids With Pneumonia 2Health News:Boffins Identify Gene That Helps Regulates Body Weight 2
(Date:9/3/2015)... Calif. , Sept. 3, 2015  Four ... in a white paper released by Leaf ... Agency for Healthcare Research & Quality (AHRQ), ... estimated $9.1-$11.6 billion annually . In addition to ... in litigation, government penalties, and negatively impact hospital ...
(Date:9/3/2015)... 3, 2015 Research and Markets ( ... "Investigation Report on China Tamsulosin Market, 2010-2019" ... Compared with other a1- adrenergic receptor blockers, tamsulosin ... lower risk of urinary tract infections and therefore ... debut in 1993 in Japan ...
(Date:9/3/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/f5wtsh/investigation ... "Investigation Report on China Phosphocreatine Market, 2010-2019" ... epidemic trend shows that cardiovascular disease has become ... whose incidence and death rate has exceeded that ... According to the World Health Organization (WHO), about ...
Breaking Medicine Technology:Four Financial Reasons to Reduce Pressure Ulcer Incidents: Leaf Healthcare Releases White Paper on Direct and Indirect Costs Associated with Pressure Ulcers 2Four Financial Reasons to Reduce Pressure Ulcer Incidents: Leaf Healthcare Releases White Paper on Direct and Indirect Costs Associated with Pressure Ulcers 3China Tamsulosin Market Investigation Report 2015 2China Phosphocreatine Market Report 2015-2019 2
... 2011 Northwest Biotherapeutics (OTC.BB: NWBO) today announced that ... exceeding its projections for the doubling of such sites ... new patients into the Company,s ongoing 240-patient randomized, double ... for Glioblastoma multiforme (GBM), the most lethal form of ...
... A study titled "Abiraterone and Increased Survival ... 26 issue of NEJM, found that ... received prior chemotherapy containing docetaxel showed a significant ... ™ (abiraterone acetate) plus prednisone compared to ...
Cached Medicine Technology:Northwest Biotherapeutics Further Expands Ongoing Brain Cancer Trial 2Northwest Biotherapeutics Further Expands Ongoing Brain Cancer Trial 3Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 2Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 3Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 4Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 5Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 6
... The Stryker Threaded ... surgeon yet another choice ... tunnel. Dilators provide compaction ... The compaction of bone ...
... Stryker Conquest Suture Retrievers ... that pierce through soft ... through the tissue to ... Conquest Retrievers are front ...
... The Arthroscopy Scissor is ideal for excising ... tissue debris in the joint. The serrated edge ... as well as hold tissue within the jaws ... left and right jaw curvatures, are the perfect ...
... offers state-of-the-art quality in an instrument of ... durability. Low profile cutting tips allow access ... I instruments are available in just about ... required for large and small joint arthroscopic ...
Medicine Products: